17th World ADC London | 8-11th March 2027 | London, UK

The preliminary agenda for the 17th World ADC London has now been released, offering a first look at the science, strategic insights and partnerships set to shape the future of antibody-drug conjugate (ADC) development. Taking place from 8-11th March 2027 in London, the event will bring together more than 700 leaders from biopharma, biotech, academia, investment and solution provider organisations for Europe’s largest annual gathering dedicated to the ADC community.

As ADCs continue to gain momentum across oncology, the industry faces a new generation of challenges and opportunities. From overcoming resistance mechanisms and improving patient response rates to advancing differentiated designs and scaling manufacturing, the need for collaboration and knowledge-sharing has never been greater. World ADC London provides a unique platform for the community to exchange ideas, learn from emerging data and explore the strategies driving the next wave of innovation.

The programme spans the full ADC development journey, covering discovery, preclinical and translational development, clinical strategy, process and analytical development, and manufacturing. Attendees will hear from more than 90 industry experts as they share scientific breakthroughs, lessons learned and practical approaches to accelerating the development of safer, more effective ADC therapies.

More than just a scientific meeting, World ADC London is recognised as the annual meeting point for the global ADC community. For 17 years, it has brought together established leaders, emerging biotech companies, investors and technology innovators in an environment designed to foster meaningful connections and productive discussions. Whether you are looking to benchmark your strategy, identify new partners, discover enabling technologies or gain a broader understanding of the competitive landscape, the event offers unrivalled opportunities to connect with the people shaping the field.

With extensive networking opportunities, dedicated partnering experiences and cutting-edge scientific content, World ADC London remains the essential forum for anyone involved in ADC development. The newly released preliminary agenda provides an early opportunity to explore the discussions, discoveries and connections that will help define the next chapter of ADC innovation and ultimately improve outcomes for patients worldwide.

View the agenda here: https://ter.li/orip0z61